New England Research & Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-2,123
| Closed | -$539K | – | 183 |
|
|
2021
Q4 | $539K | Sell |
2,123
-428
| -17% | -$109K | 0.26% | 106 |
|
|
2021
Q3 | $982K | Sell |
2,551
-149
| -6% | -$57.4K | 0.51% | 69 |
|
|
2021
Q2 | $634K | Buy |
2,700
+1,150
| +74% | +$270K | 0.33% | 101 |
|
|
2021
Q1 | $203K | Sell |
1,550
-4,100
| -73% | -$537K | 0.11% | 166 |
|
|
2020
Q4 | $590K | Buy |
+5,650
| New | +$590K | 0.36% | 90 |
|